Autologous Cell Therapy Market to Hit Valuation of US$ 44.55 Billion By 2033 | Astute Analytica Read more
Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle Read more
Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | MarketsandMarkets™ Read more
MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Read more
North America Leads Specialty Enzymes Market Amid Rising Demand for Diagnostics and Therapeutics Read more
Cancer Gene Therapy Market to Surpass Valuation of US$ 17.57 Billion By 2033 | Astute Analytica Read more
Charging Robotics: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle Read more
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million Read more
Cognitive Computing Market to Hit Valuation of US$ 285.72 Billion by 2033 | Astute Analytica Read more